Don’t miss out: March Editor’s Choice in IJGC. Dive into the latest in gynecologic cancer research now: https://abrv.in/cOn1.
About us
- Website
-
https://www.elsevier.com/subject/medicine/oncology-journal-network
External link for Elsevier Oncology
- Industry
- IT Services and IT Consulting
Updates
-
Delighted to share the latest Annals of Oncology podcast on using AI to process patient records. You can listen on SoundCloud here https://abrv.in/cMn5; or on Spotify here https://abrv.in/a1tS. In this episode we explore practical applications, the evidence behind AI in clinical data processing, and what this could mean for oncology research and patient care.
-
We’re excited to spotlight the ROB Special Issue in The Red Journal, now live, along with its companion podcast. This issue highlights robotics-driven advances in radiation oncology—from innovative delivery systems and automation to quality assurance and clinical outcomes. The companion podcast features editors and authors discussing the implications for practice, research, and education in our field. Read the current issue: https://abrv.in/fHnD Listen to the companion podcast: current Listen to the companion podcast: https://abrv.in/jsma We invite clinicians, physicists, and researchers to explore the latest findings and share their perspectives. If you find these resources valuable, please comment with your take or tag colleagues who might be interested.
-
-
Elsevier Oncology reposted this
HER2-mutant NSCLC has historically been aggressive, with limited targeted options. That’s FINALLY changing! This latest review captures the evolution from ADCs to more selective HER2-targeted TKIs designed to reduce off-target toxicity while maintaining efficacy. https://lnkd.in/g9mT898q
-
As part of Women’s History Month, Transplantation and Cellular Therapy is proud to highlight recent articles published by our female Associate Editors and Editorial Board Members. Their outstanding contributions continue to advance the field and inspire the next generation of leaders. These articles are available for FREE until April 1st — don’t miss the opportunity to read and celebrate their impactful work: https://abrv.in/jGlE
-
-
March Editor’s Choice from the Journal of Thoracic Oncology: https://abrv.in/h2ps Journal of Thoracic Oncology 20th Anniversary Series Surgery – Agrafiotis AC et al Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee – Zhu H et al First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study – Reck M et al Clinical Significance of MTAP��Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer – Ross JS et al
-
-
Read the latest important articles from ESMO journals on cancer research and treatment https://abrv.in/iloo
-
-
🚨 Concomitant Paper Released Today! A new article has just been released in Annals of Oncology— check it out. Read it here: https://abrv.in/jAlK
-
-
🎙️ New Annals of Oncology Podcast Episode Now Live A new episode of the Annals of Oncology Podcast is available! In this discussion, experts explore the latest insights from a pooled analysis study — unpacking what the findings mean for clinical practice and future research. If you're following developments in oncology, this is one you won’t want to miss. 🎧 Listen here: SoundCloud: https://abrv.in/cdph #Oncology #CancerResearch #MedicalResearch #AnnalsOfOncology #Podcast
-
Have you listened to the latest Annals of Oncology podcast episode? This episode dives into DESTINY-Breast11, a phase III study of T-DXd for patients with high-risk HER2-positive early breast cancer. 🎧 Listen now (SoundCloud): https://abrv.in/gStW